Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NY:
ZYME
)
6.430
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Zymeworks Inc
< Previous
1
2
3
4
5
6
7
Next >
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying
June 22, 2023
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
The 3 Most Undervalued Growth Stocks for Your June Buy List
June 11, 2023
Sometimes you can get the best of both worlds in the equities sector, which should draw interest for these undervalued growth stocks.
Via
InvestorPlace
7 Analysts Have This to Say About Zymeworks
June 06, 2023
Via
Benzinga
3 Cheap Growth Stocks That Are Too Good to Pass Up
June 05, 2023
These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
May 29, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Zymeworks
May 18, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 10, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Zymeworks
March 31, 2023
Via
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Earnings Scheduled For May 8, 2023
May 08, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
Via
Benzinga
The 7 Most Undervalued Stocks You Need to Know About
April 18, 2023
Given the risks targeting highly popular trades right now, the most undervalued stocks to buy may offer greater mileage.
Via
InvestorPlace
Analyst Ratings for Zymeworks
March 08, 2023
Via
Benzinga
Earnings Preview: Zymeworks
March 06, 2023
Via
Benzinga
$3M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
January 24, 2023
Although US stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
Analyst Ratings for Zymeworks BC
January 20, 2023
Via
Benzinga
Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks
December 21, 2022
Via
Benzinga
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
March 08, 2023
Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1...
Via
Benzinga
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 19, 2023
Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
Via
Benzinga
6 Analysts Have This to Say About Zymeworks BC
December 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 19, 2023
We're starting off Thursday with an overview of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
January 19, 2023
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Around $8 Million Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying
January 13, 2023
Although US stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
20 Favorite Biotech & Medical Stocks For 2023
December 28, 2022
The way these stocks are setting up, many of them look great and will be at the forefront this coming year.
Via
Talk Markets
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
Stifel raised argenx SE (NASDAQ: ARGX) price target from $471 to $478. Stifel analyst Alex Thompson maintained a Buy rating on the stock. argenx shares rose 1.1% to $387.07 in pre-market trading.
Via
Benzinga
Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors' Attention Today
December 21, 2022
U.S. markets soared on Wednesday as consumer confidence surged to an eight-month high in December following a drop in inflation and the labor market remaining strong. Twelve-month inflation...
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.